Ranibizumab Therapy for Choroidal Neovascularization (CNV) Asociated With Angioid Streaks
Status:
Withdrawn
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether injections of ranibizumab into the eye are
safe and well tolerated when given to subjects in multiple doses.